Goldman Sachs launched a specialty finance company to invest in risky credit products.

Goldman has registered the fund as a "business development company" -- a type of investment vehicle that has grown in popularity over the past decade, and which allows Goldman to avoid certain regulations, according to The Wall Street Journal.

AstraZeneca's patent for its Pulmicort Respules asthma treatment has been ruled invalid by a U.S. court.

The ruling allows Actavis to launch a generic version of the drug; Actavis said it would do so immediately.

U.S. automakers, including Ford and General Motors, are scheduled Tuesday to release auto sales for March.

U.S. car and truck sales are expected to hit their highest level in nearly six years in March, according to analysts surveyed by Bloomberg.